Compass Therapeutics CMPX
NASDAQ CMPX
$0.81 -0.02 (-2.26%)
At close: Oct 21, 2026 · 4:00 PM EDT

Compass Therapeutics (CMPX) EBITDA Margin (2024)

Updated

Compass Therapeutics' EBITDA Margin came in at -6592.47% for FY2024.

Analysis

Compass Therapeutics (CMPX) EBITDA Margin (2024) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBITDA Margin (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn 53.49%
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn 35.95%
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn 49.01%
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn 6.02%
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn -
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn 33.11%
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn 46.01%
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn -124.26%
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn 39.16%
10 Compass Therapeutics 152.17 Mn -653.47 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2024 -1,752.12%
API Access

Compass Therapeutics EBITDA Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebitda-margin&ticker=CMPX&period=max&api_key=YOUR_API_KEY